MetaCap

Mentari Therapeutics (MTRI) News

NASDAQ: MTRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.70-0.545 (-3.57%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MTRI news summary

We found 3 recent headlines mentioning Mentari Therapeutics (MTRI): 1 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, MTRI is down 3.57% at $14.70. The most recent story, "InMed Pharmaceuticals Inc. Files Unaudited Financial Statements of Mentari Therapeutics as of September 30, 2026", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Mentari Therapeutics headlines

Compare MTRI